- Home
- ARMK vs PEN Comparison
ARMK vs PEN Comparison
Compare ARMK & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARMK | PEN |
|---|---|---|
| Founded | 1959 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2B | 12.6B |
| IPO Year | 2013 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ARMK | PEN |
|---|---|---|
| Price | $55.30 | $321.04 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 16 | 17 |
| Target Price | $68.59 | ★ $362.54 |
| AVG Volume (30 Days) | ★ 2.0M | 357.4K |
| Earning Date | 11-16-2026 | 11-04-2026 |
| Dividend Yield | ★ 0.87% | N/A |
| EPS Growth | 23.23 | ★ 1155.56 |
| EPS | 1.11 | ★ 1.70 |
| Revenue | ★ $18,506,299,000.00 | $1,403,665,000.00 |
| Revenue This Year | $8.66 | $13.46 |
| Revenue Next Year | $8.84 | $13.01 |
| P/E Ratio | ★ $49.58 | $189.07 |
| Revenue Growth | 6.35 | ★ 17.50 |
| 52 Week Low | $35.07 | $221.26 |
| 52 Week High | $62.65 | $362.41 |
Technical Indicators
Market Signals| Indicator | ARMK | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 46.18 | 55.76 |
| Support Level | $53.00 | $315.42 |
| Resistance Level | $55.95 | $324.05 |
| Average True Range (ATR) | 0.99 | 1.80 |
| MACD | 0.11 | 0.54 |
| Stochastic Oscillator | 71.16 | 77.35 |
Price Performance
Historical ComparisonAbout ARMK Aramark
Aramark, founded in 1936 and headquartered in Philadelphia, Pennsylvania, is a foodservice company that provides facility management and workplace solutions. The company primarily generates revenue from its North American food and support services segment, serving clients such as schools, healthcare facilities, and entertainment venues.
About PEN Penumbra Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.